drugset / Trial / NCT00460681
Study of Thymopentin in Patients After Curative Resection of Small Hepatocellular Carcinoma
RandomizedParallel-groupOpen-labelPrevention
Summary
The purpose of this study is to evaluate the clinical efficacy of thymopentin on the prevention of the recurrence and metastasis of small HCC after resection.
Timeline
- Start
- 2007-02
- Primary completion
- —
- Completion
- 2012-02
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Thymopentin | Peptide | 10 mg | Subcutaneous |